frequency – Pharma GMP

How to Justify In-Process Testing Frequency for Parenteral Products

digi — Wed, 26 Nov 2025 03:06:04 +0000

How to Justify In-Process Testing Frequency for Parenteral Products Step-by-Step Guide to Justify In-Process Testing Frequency for Parenteral Products In pharmaceutical manufacturing, in process checks for filled vials are a critical control point ensuring product safety, efficacy, and compliance with regulatory requirements. For parenteral products, any deviation or failure in in-process testing may compromise patient...

How to Design Calibration Schedules Based on Risk and Usage

digi — Tue, 25 Nov 2025 11:57:04 +0000

How to Design Calibration Schedules Based on Risk and Usage Step-by-Step Tutorial: Designing a Calibration Program for QC Laboratory Instruments Using Risk-Based Methodology Calibration of laboratory instruments in pharmaceutical quality control (QC) plays a pivotal role in ensuring data integrity, product quality, and regulatory compliance. Establishing an effective calibration program for QC laboratory instruments requires...

Room Cleaning Frequency and Documentation in GMP Facilities

digi — Tue, 25 Nov 2025 01:36:42 +0000

Room Cleaning Frequency and Documentation in GMP Facilities Effective Room Cleaning Frequency and Documentation in GMP Manufacturing Areas Environmental cleaning in manufacturing areas is a critical component of Good Manufacturing Practice (GMP) compliance, ensuring consistent product quality, patient safety, and regulatory adherence. This article provides a detailed, step-by-step tutorial on establishing and maintaining room cleaning...

How to Justify In-Process Testing Frequency for Parenteral Products

digi — Mon, 24 Nov 2025 21:54:42 +0000

How to Justify In-Process Testing Frequency for Parenteral Products Step-by-Step Guide to Justify In-Process Testing Frequency for Parenteral Products In pharmaceutical manufacturing, ensuring the quality and safety of parenteral products demands rigorous in-process testing during critical production stages. One frequent challenge is to appropriately determine and justify the frequency of these tests to meet regulatory...

How to Justify In-Process Control Frequency to FDA and EU Inspectors

digi — Mon, 24 Nov 2025 18:51:42 +0000

How to Justify In-Process Control Frequency to FDA and EU Inspectors Step-by-Step Guide to Justify In-Process Control Frequency for Tablet Manufacturing In the pharmaceutical industry, in-process controls (IPCs) are essential checkpoints to ensure product quality during manufacturing. Regulatory bodies such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the...

How to Justify In-Process Control Frequency to FDA and EU Inspectors

digi — Mon, 24 Nov 2025 18:51:42 +0000

How to Justify In-Process Control Frequency to FDA and EU Inspectors Step-by-Step Guide on How to Justify In-Process Control Frequency to FDA and EU Inspectors In pharmaceutical manufacturing, ensuring product quality through effective in-process controls (IPCs) is a regulatory requirement enforced by agencies such as the FDA, EMA, and MHRA. One critical aspect for manufacturing,...

Audit Trail Review Under 21 CFR Part 11: Practical Techniques and Schedules

digi — Sat, 15 Nov 2025 08:56:47 +0000

Audit Trail Review Under 21 CFR Part 11: Practical Techniques and Schedules Step-by-Step Guide to Effective Audit Trail Review for 21 CFR Part 11 Compliance The principles of 21 CFR Part 11 data integrity set a stringent regulatory framework for electronic records and signatures used in pharmaceutical manufacturing environments. One of the cornerstone requirements under...